Forest Receives Info Request From N.Y. Attorney General
This article was originally published in The Pink Sheet Daily
Executive Summary
State Attorney General Eliot Spitzer is requesting information related to off-label clinical trials and product promotion, Forest says. The request follows a recent suit against GSK over pediatric data for Paxil.
You may also be interested in...
Forest Settles With Spitzer, Will Post All Phase III-IV Results On-Line
Forest Labs has agreed to post summaries of all Phase III and Phase IV trials on the Internet to resolve an investigation into the company by New York Attorney General Eliot Spitzer
Forest Settles With Spitzer, Will Post All Phase III-IV Results On-Line
Forest Labs has agreed to post summaries of all Phase III and Phase IV trials on the Internet to resolve an investigation into the company by New York Attorney General Eliot Spitzer
J&J Is Spitzer's Next Target: New York AG Opens Broad Off-Label Promotion Investigation
Procrit, Risperdal and four other leading J&J pharmaceutical brands are the subject of a document request from New York Attorney General Eliot Spitzer. J&J is already facing two federal investigations into marketing practices.